Bagri Harkaryn, Dahri Karen, Legal Michael
, BSc, BScPharm, ACPR, is a Clinical Pharmacist with Surrey Memorial Hospital, Surrey, British Columbia.
, BSc, BScPharm, PharmD, ACPR, BCPS, is a Clinical Pharmacotherapeutic Specialist (Internal Medicine) with Vancouver General Hospital and a Clinical Instructor with the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
Can J Hosp Pharm. 2019 Jul-Aug;72(4):288-294. Epub 2018 Aug 31.
Pharmacists often overlook drug interaction alerts because of limitations in clinical decision support (CDS) software systems intended to detect evidence-based, clinically significant drug-drug interactions (DDIs). Alert fatigue, which occurs when pharmacists become desensitized to an overload of DDIs, may also contribute.
To gain a better understanding of how pharmacists assess common DDIs and the extent to which computerized drug alerts affect their decision-making, as background for initiatives to overcome alert fatigue and improve detection of DDIs.
This qualitative study used focus group methodology. A structured focus group was planned at each of 3 large tertiary hospitals. Pharmacists were invited to participate if their jobs included patient care and/or dispensary responsibilities. The focus group discussions were audio-recorded and subsequently transcribed, analyzed, and coded into themes using NVivo software. Four main categories of themes were identified: perceived challenges, pharmacists' assessment of DDIs, barriers to responding to alerts, and proposed solutions.
The participants ( = 24) described a large discrepancy among CDS software systems in terms of the severity of specific DDIs, which made it difficult to view these systems as reliable sources. The participants agreed that alert fatigue is present and contributes to DDIs being overlooked. However, lack of patient information to make an initial assessment, as well as the constant need for multitasking, prevents pharmacists from focusing on the evaluation of DDIs.
Although alert fatigue was reported to be a common factor responsible for pharmacists missing DDIs, other barriers also exist. Participants suggested ways to limit DDI alerts to those that are clinically relevant. Having a collaborative team of pharmacists periodically review the DDIs embedded in the CDS system, incorporating a colour-code system, and removing duplicate entries were discussed as ways to improve system efficiency.
由于旨在检测循证的、具有临床意义的药物相互作用(DDIs)的临床决策支持(CDS)软件系统存在局限性,药剂师常常会忽略药物相互作用警报。药剂师对大量DDIs警报变得麻木不仁时出现的警报疲劳也可能起到了一定作用。
为了更好地了解药剂师如何评估常见的DDIs,以及计算机化药物警报在多大程度上影响他们的决策,作为克服警报疲劳和改善DDIs检测的举措的背景。
本定性研究采用焦点小组方法。计划在3家大型三级医院各组织一次结构化焦点小组。如果药剂师的工作包括患者护理和/或配药职责,则邀请他们参加。焦点小组讨论进行了录音,随后进行转录、分析,并使用NVivo软件编码成主题。确定了四个主要主题类别:感知到的挑战、药剂师对DDIs的评估、应对警报的障碍以及提出的解决方案。
参与者(=24)描述了CDS软件系统在特定DDIs严重程度方面存在很大差异,这使得很难将这些系统视为可靠来源。参与者一致认为存在警报疲劳,这导致DDIs被忽视。然而,缺乏用于初步评估的患者信息以及持续需要同时处理多项任务,使得药剂师无法专注于DDIs的评估。
尽管警报疲劳被报告是药剂师遗漏DDIs的一个常见因素,但其他障碍也存在。参与者提出了将DDI警报限制在与临床相关的警报的方法。讨论了让药剂师协作团队定期审查CDS系统中嵌入的DDIs、采用颜色编码系统以及删除重复条目等方法,以提高系统效率。